Canopus BioPharma Incorporated
Canopus BioPharma Incorporated (CBIA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CBIA · as of Jun 8, 2026
Key Statistics
Explore Canopus BioPharma Incorporated Data
cbia stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
cbia competitorsCBIA
AGIN
APHD
CCWF
CHIF
FBDSStock Performance
Full HistoryAbout Canopus BioPharma Incorporated
Canopus BioPharma Incorporated a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also pro…
what is canopus biopharma incorporated · cbia stock overview · canopus biopharma incorporated company profile · who is canopus biopharma incorporated ceo · cbia OTC · canopus biopharma incorporated headquarters · canopus biopharma incorporated business segments
About Stock Overview & Key Data
Canopus BioPharma Incorporated (CBIA) is a Financial Services company in the Shell Companies industry, listed on OTC since Dec 31, 1999. As of the latest trading session, CBIA stock price is $0.00, with a market capitalization of $455,071. The stock has returned +0.00% over the past 12 months and +9900.00% year-to-date.
In fiscal year 2022, Canopus BioPharma Incorporated reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Canopus BioPharma Incorporated (CBIA) stock price is $0.00. The stock is traded on OTC under the ticker symbol CBIA. The 52-week range is $0.00 – $0.00.